Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BELANTAMAB MAFODOTIN vs BELATACEPT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BELANTAMAB MAFODOTIN vs BELATACEPT: Safety Overview

Metric BELANTAMAB MAFODOTIN BELATACEPT
Total FAERS Reports 2,293 3,410
Deaths Reported 843 589
Death Rate 36.8% 17.3%
Hospitalizations 599 1,283
Average Patient Age 67.3 yrs 54.6 yrs
% Female Patients 39.2% 40.8%
Manufacturer GlaxoSmithKline LLC E.R. Squibb & Sons, L.L.C.
Route INTRAVENOUS INTRAVENOUS
Marketing Status N/A Prescription